https://pressroom.prlog.org/Aciont/ About Aciont Inc - Aciont is a specialty biopharmaceutical company focused on commercializing localized, non-invasive, controlled and sustained release back of the eye therapeutics for sight threatening diseases. https://www.prlog.org/11768742-aciont-to-present-on-visulextm-technologies-at-the-4th-ocular-drug-discovery-conference.html Dr. Kongnara Papankorn and Dr. Sarah Molokhia will present on behalf of Aciont Inc at the Global Technology Community’s 4th Ocular & Drug Discovery Conference, February 27-28, 2012, in Las Vegas, NV.Tue, 10 Jan 2012 21:38:28 GMT https://www.prlog.org/11458704-aciont-to-present-at-arvo-2011-annual-meeting.html Aciont’s poster “Importance of the Conjunctiva in Transscleral Iontophoresis” will be shown on May 3, 2011 at the meeting.Tue, 26 Apr 2011 20:10:56 GMT https://www.prlog.org/11284507-aciont-ceo-to-present-at-in3-west-medical-device-conference.html John Higuchi will present on behalf of Aciont Inc at the IN3 West Medical Device Conference in Las Vegas, NV on February 22, 2011.Tue, 08 Feb 2011 22:34:46 GMT https://www.prlog.org/11048316-aciont-awarded-two-qualifying-therapeutic-discovery-project-grants-totaling-489k.html Aciont Inc. receieves a total of $489K in grants for two ongoing ophthalmology projectsThu, 04 Nov 2010 21:31:08 GMT https://www.prlog.org/10780216-the-nih-awards-aciont-small-business-catalyst-award-grant-accelerating-innovative-research.html Aciont is awarded a phase I SBIR $214K grant for the project titled “Novel Method for the Ocular Iontophoretic Delivery of Avastin® and Lucentis®”Tue, 06 Jul 2010 23:29:11 GMT https://www.prlog.org/10724737-aciont-ceo-to-present-at-in3-east-medical-device-conference.html John Higuchi will present on behalf of Aciont Inc at the IN3 East Medical Device Conference in Boston, MA on June 10, 2010.Tue, 08 Jun 2010 17:33:06 GMT https://www.prlog.org/10619004-aciont-to-present-at-arvo-2010-annual-meeting.html Aciont’s poster “Transscleral Passive Delivery of Rapamycin in Rabbit Using a Visulex Topical Application Device” will be shown on May 6, 2010 at the meeting.Fri, 09 Apr 2010 19:38:11 GMT https://www.prlog.org/10608341-aciont-strengthens-management-team-with-industry-leader-in-ophthalmic-product-development.html Balbir Brar brings 25 years of drug and device development experience to Aciont Inc.Fri, 02 Apr 2010 19:53:56 GMT https://www.prlog.org/10447121-nei-awards-twoyear-218-million-sbir-grant-to-aciont.html The National Eye Institute (NEI) awarded a $2.18 million grant to Aciont Inc. to help fund its development of a non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis.Thu, 10 Dec 2009 19:40:31 GMT